Interpretable machine learning models for the prediction of all-cause mortality and time to death in hemodialysis patients

被引:1
|
作者
Chen, Minjie [1 ]
Zeng, Youbing [2 ]
Liu, Mengting [2 ]
Li, Zhenghui [1 ]
Wu, Jiazhen [3 ]
Tian, Xuan [1 ]
Wang, Yunuo [1 ]
Xu, Yuanwen [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sch Biomed Engn, Shenzhen, Peoples R China
[3] Shantou Univ, Dept Elect Engn, Shantou, Peoples R China
关键词
hemodialysis; interpretability; machine learning; mortality; prediction models; RANDOM FOREST REGRESSION; CHRONIC KIDNEY-DISEASE; SUDDEN CARDIAC DEATH; VASCULAR ACCESS; RISK; HOSPITALIZATION; COMPLICATIONS; INFECTIONS; RATES;
D O I
10.1111/1744-9987.14212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe elevated mortality and hospitalization rates among hemodialysis (HD) patients underscore the necessity for the development of accurate predictive tools. This study developed two models for predicting all-cause mortality and time to death-one using a comprehensive database and another simpler model based on demographic and clinical data without laboratory tests.MethodA retrospective cohort study was conducted from January 2017 to June 2023. Two models were created: Model A with 85 variables and Model B with 22 variables. We assessed the models using random forest (RF), support vector machine, and logistic regression, comparing their performance via the AU-ROC. The RF regression model was used to predict time to death. To identify the most relevant factors for prediction, the Shapley value method was used.ResultsAmong 359 HD patients, the RF model provided the most reliable prediction. The optimized Model A showed an AU-ROC of 0.86 +/- 0.07, a sensitivity of 0.86, and a specificity of 0.75 for predicting all-cause mortality. It also had an R2 of 0.59 for predicting time to death. The optimized Model B had an AU-ROC of 0.80 +/- 0.06, a sensitivity of 0.81, and a specificity of 0.70 for predicting all-cause mortality. In addition, it had an R2 of 0.81 for predicting time to death.ConclusionTwo new interpretable clinical tools have been proposed to predict all-cause mortality and time to death in HD patients using machine learning models. The minimal and readily accessible data on which Model B is based makes it a valuable tool for integrating into clinical decision-making processes.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] INTRACELLULAR WATER BEFORE HEMODIALYSIS PREDICTS ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS
    Ekart, Robert
    Keber, Gasper
    Hojs, Nina Vodosek
    Jakopin, Eva
    Piko, Nejc
    Bevc, Sebastjan
    Hojs, Radovan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 460 - 460
  • [32] Stress hyperglycemia ratio and machine learning model for prediction of all-cause mortality in patients undergoing cardiac surgery
    Pei, Yingjian
    Ma, Yajun
    Xiang, Ying
    Zhang, Guitao
    Feng, Yao
    Li, Wenbo
    Zhou, Yinghua
    Li, Shujuan
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [33] Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity
    Fu, Xiaohong
    Yang, Jihong
    Fan, Zhaoxin
    Chen, Xianguang
    Wu, Jie
    Li, Jie
    Wu, Hua
    CLINICAL NEPHROLOGY, 2016, 85 (02) : 92 - 100
  • [34] Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
    Zawada, Adam M.
    Wolf, Melanie
    Rincon Bello, Abraham
    Ramos-Sanchez, Rosa
    Hurtado Munoz, Sara
    Ribera Tello, Laura
    Mora-Macia, Josep
    Fernandez-Robres, M. Amparo
    Soler-Garcia, Jordi
    Aguilera Jover, Josep
    Moreso, Francesc
    Stuard, Stefano
    Stauss-Grabo, Manuela
    Winter, Anke
    Canaud, Bernard
    BMC NEPHROLOGY, 2023, 24 (01)
  • [35] Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
    Adam M Zawada
    Melanie Wolf
    Abraham Rincon Bello
    Rosa Ramos-Sanchez
    Sara Hurtado Munoz
    Laura Ribera Tello
    Josep Mora-Macia
    M. Amparo Fernández-Robres
    Jordi Soler-Garcia
    Josep Aguilera Jover
    Francesc Moreso
    Stefano Stuard
    Manuela Stauss-Grabo
    Anke Winter
    Bernard Canaud
    BMC Nephrology, 24
  • [36] Prediction of All-Cause Mortality Using an Echocardiography-Based Risk Score in Hemodialysis Patients
    Zhu, Jing
    Tang, Chao
    Ouyang, Han
    Shen, Huaying
    You, Tao
    Hu, Ji
    CARDIORENAL MEDICINE, 2021, 11 (01) : 33 - 43
  • [37] Machine Learning and Prediction of All-Cause Mortality in COPD (vol 158, pg 952, 2020)
    Moll, Matthew
    Qiao, Dandi
    Regan, Elizabeth A.
    Hunninghake, Gary M.
    Make, Barry J.
    Tal-Singer, Ruth
    McGeachie, Michael J.
    Castaldi, Peter J.
    Estepar, Raul San Jose
    Washko, George R.
    Wells, James M.
    LaFon, David
    Strand, Matthew
    Bowler, Russell P.
    Han, MeiLan K.
    Vestbo, Jorgen
    Celli, Bartolome
    Calverley, Peter
    Crapo, James
    Silverman, Edwin K.
    Hobbs, Brian D.
    Cho, Michael H.
    CHEST, 2021, 159 (05) : 2123 - 2128
  • [38] IMPACT OF POLYPHARMACY ON ALL-CAUSE MORTALITY, ALL-CAUSE HOSPITALIZATION AND CARDIOVASCULAR EVENTS IN INITIAL JAPANESE HEMODIALYSIS PATIENTS
    Toida, Tatsunori
    Toida, Reiko
    Ebihara, Shou
    Uezono, Shigehiro
    Komatsu, Hiroyuki
    Sato, Yuji
    Fujimoto, Shouichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1831 - 1831
  • [39] Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients
    Okazaki, Masayuki
    Komatsu, Mizuki
    Kawaguchi, Hiroshi
    Tsuchiya, Ken
    Nitta, Kosaku
    BLOOD PURIFICATION, 2014, 37 (02) : 106 - 112
  • [40] Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Beberashvili, Ilia
    Katkov, Anna
    Sinuani, Inna
    Azar, Ada
    Shapiro, Gregory
    Feldman, Leonid
    Gorelik, Oleg
    Stav, Kobi
    Efrati, Shai
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (04) : 254 - 265